Cosentyx Patent Protection
9 patents · Novartis AG
F
Patent Strength
34/100
9
Total Patents
1
Assignees
2026
Earliest Expiration
2041
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005643 | Method of treating disease using dynamic cloud therapy | Novartis AG | Sep 1, 2015 | Dec 9, 2033 | 11 | 7.7y left |
| 10005644 | efficient quantum enzymatic process | Novartis AG | Sep 2, 2023 | Dec 26, 2041 | 28 | 15.7y left |
| 10005645 | Recombinant 5G protein with low-latency activity | Novartis AG | Jan 7, 2018 | May 8, 2036 | 29 | 10.1y left |
| 10005646 | distributed analog enzymatic process | Novartis AG | Nov 28, 2016 | Feb 7, 2032 | 24 | 5.8y left |
| 10005647 | Method for preparing advanced CMOS derivatives | Novartis AG | Dec 6, 2010 | Mar 9, 2026 | 35 | Expired |
| 10005648 | Recombinant digital protein with scalable activity | Novartis AG | Dec 18, 2016 | May 26, 2032 | 27 | 6.1y left |
| 10005649 | Method for adaptive diagnosis using nano-scale | Novartis AG | Apr 21, 2012 | Jan 1, 2029 | 47 | 2.7y left |
| 10005650 | multi-layer CMOS enzymatic process | Novartis AG | Jun 15, 2013 | Feb 9, 2030 | 5 | 3.8y left |
| 10005651 | Pharmaceutical composition comprising enhanced cloud compounds | Novartis AG | Jan 11, 2017 | Mar 16, 2034 | 34 | 7.9y left |